Literature DB >> 3977513

Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases.

J Sotelo, V Guerrero, F Rubio.   

Abstract

Cysticercosis of the central nervous system, because of the combination of inflammatory response, topography of lesions, degree of parasitic infestation, and sequelae of previous infestations produces a most variable clinical picture. The symptomatology may range from a discrete neurological disturbance to the most dramatic brain disorder. Severity of the disease, prognosis, and medical or surgical decision for treatment largely depend on the individual amalgam of the above-referred factors. An improved classification of neurocysticercosis (NCC) that delineates active from inactive forms of the disease will eventually be important in the research of immunodiagnosis and in therapeutic trials. In this report, a classification is presented that separates active from nonactive forms of NCC and is based on our experience with 735 patients studied. Characteristics of each form of NCC, frequency of principal signs and symptoms, and findings in cerebrospinal fluid analysis are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3977513

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  64 in total

1.  Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis.

Authors:  E C Bueno; A J Vaz; L R Machado; J A Livramento; S L Avila; A W Ferreira
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Is the presence of depression independent from signs of disease activity in patients with neurocysticercosis?

Authors:  Sergio Monteiro de Almeida; Solange Aparecida Gurjão
Journal:  J Community Health       Date:  2011-10

3.  Cysticercosis.

Authors:  J F Bale
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

Review 4.  Rhombencephalitis / brainstem encephalitis.

Authors:  Burk Jubelt; Cornelia Mihai; Terrence M Li; Padma Veerapaneni
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

5.  Neurocysticercotic versus idiopathic epilepsy: a comparative study of 175 patients.

Authors:  W O Arruda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

6.  Isolated third cranial nerve palsy: a rare presentation of neurocysticercosis.

Authors:  M P Ranjith; R Divya; A Sahni
Journal:  Ir J Med Sci       Date:  2009-04-02       Impact factor: 1.568

7.  A new complement fixation test for the diagnosis of neurocysticercosis in cerebrospinal fluid.

Authors:  E Garcia; J Sotelo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

Review 8.  Epidemiology of epilepsy in developing countries.

Authors:  N Senanayake; G C Román
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

9.  Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study.

Authors:  Theodore E Nash; E Javier Pretell; Andres G Lescano; Javier A Bustos; Robert H Gilman; Armando E Gonzalez; Héctor H Garcia
Journal:  Lancet Neurol       Date:  2008-11-03       Impact factor: 44.182

Review 10.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.